Skip to main content
TipRanks
Go Ultimate75% OFF

Bruce N. Jacobs Insider Profile

4 Followers

Bruce N. Jacobs, CFO at Kymera Therapeutics, holds 244.88K shares in Kymera Therapeutics (Ticker: KYMR).

Bruce N. Jacobs's Trading History

KYMR
Kymera Therapeutics
Jul 02, 2026CFOUninformative Buy327.14K$31.24M
KYMR
Insider Shares: 244.88K (0.30%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jul 02, 2026Uninformative Sell$8.86M77,109$114.95―
Jul 02, 2026Uninformative Buy$327.14K61,378$5.33―
Jun 03, 2026Uninformative Buy$26.32K12,653$2.08―
May 19, 2026Uninformative Buy$31.20K15,000$2.08―
Mar 04, 2026Informative Sell$1.09M12,471$87.49-48.10%

You May Also Like

Bruce N. Jacobs insider profile FAQ

What is the percentage of profitable transactions made by Bruce N. Jacobs?
The percentage of profitable transactions made by Bruce N. Jacobs is 33%.
What is the average return per transaction made by Bruce N. Jacobs?
The average return per transaction made by Bruce N. Jacobs is -68.80%.
What stocks does Bruce N. Jacobs hold?
Bruce N. Jacobs holds: KYMR stocks.
What was Bruce N. Jacobs’s latest transaction?
Bruce N. Jacobs’s latest transaction was an Uninformative Buy of $327.14K.
What was Bruce N. Jacobs's most profitable transaction?
Bruce N. Jacobs’s most profitable transaction was an Informative Sell of KYMR stock on March 4, 2024. The return on the trade was 27.90%.
What is Bruce N. Jacobs's role in Kymera Therapeutics?
Bruce N. Jacobs's role in Kymera Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.